CS267380B1 - Method of 6-amino-5-bromo-1-methyl-1 h-pyrimidine-2,4-dione preparation - Google Patents
Method of 6-amino-5-bromo-1-methyl-1 h-pyrimidine-2,4-dione preparation Download PDFInfo
- Publication number
- CS267380B1 CS267380B1 CS883553A CS355388A CS267380B1 CS 267380 B1 CS267380 B1 CS 267380B1 CS 883553 A CS883553 A CS 883553A CS 355388 A CS355388 A CS 355388A CS 267380 B1 CS267380 B1 CS 267380B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- pyrimidine
- methyl
- amino
- bromo
- Prior art date
Links
Abstract
Riešenie sa týká spósobu přípravy 6-amíno - 5 - bróm -1 - metyl-1H - pyrimidín - 2,4 - dionu vzorca I, ktorý sa používá vo farmaceutickej chémii ako medziprodukt pri syntéze liečiva prepentofylín. Připravuje sa zo 6-amíno-l-metyl-lH-pyrimidín-2,6-dionu vzorca II a brómu v prostředí kyseliny octovej za přítomnosti octanu sodného alebo draselného, viažúceho uvoFňujúci sa bromovodík, pri teplote 15 až 80 °C.The solution relates to a method of preparing 6-amine 5-bromo-1-methyl-1H-pyrimidine-2,4-dione of formula I which is used in pharmaceutical formulations chemistry as an intermediate in drug synthesis prepentophyllin. Prepared from 6-amino-1-methyl-1H-pyrimidine-2,6-dione of formula II and bromine in acetic acid in the presence of acetate sodium or potassium binding releasing hydrogen bromide at 15 to 80 ° C.
Description
Vynález sa týká spósobu přípravy 6-amíno5-bróm-1 -metyl-1 H-pyrimidín-2,4-dionu vzorca IThe invention relates to a process for the preparation of 6-amino-5-bromo-1-methyl-1H-pyrimidine-2,4-dione of formula I
OABOUT
ktorý sa používá vo farmaceutické] chémii ako medziprodukt pri syntéze vazodilatancia propentofylínu.which is used in pharmaceutical chemistry as an intermediate in the synthesis of the vasodilator propentophylline.
Doposial’ sa táto zlúčenina připravovala zo 6-amíno-1 -metyl-1 H-pyrimidín-2,6-dionu vzorca IIHitherto, this compound was prepared from 6-amino-1-methyl-1H-pyrimidine-2,6-dione of formula II
OABOUT
h bromáciou vo vodnom prostředí pri teplote miestnosti vo výťažku 23 % [G. R. Barker, N. G. Luthy: J. Chem. Soc. 1956. 920] alebo v kyselině octovej vo výťažku nad 90 % (surový produkt) [J. Wojciechowski: Acta Polon. Pharm. 18, 409 (1961): PL 42, 976]. Nevýhodou prvého postupu je práca vo vodnom prostředí, v ktorom dochádza z častí k hydrolýze amínoskupiny v polohe 6 zlúčeniny vzorca II. U druhého postupu spósobuje reakciou vznikajúca kyselina bromovodíková taktiež nežiadúce reakcie. Vznik nečistot pri reakcii sa prejaví v podstatnom znížení výťažkov pri čistění zlúčeniny vzorca 1 a tiež v znížení kvality produktu po prekryštalizácii, čo vyplývá z porovnania teploty topenia produktu podlá postupu uvedeného v druhom lit. odkaze (265 °C) a postupu podťa 1. lit. odkazu (278 až 280 °C). Uvedené nevýhody odstraňuje spósob přípravy zlúčeniny vzorca I podťa vynálezu, ktorého podstatou je bromácia zlúčeniny vzorca II v prostředí kyseliny octovej za přítomnosti octanu sodného alebo draselného, ktoré viažu v reakcii sa uvoťňujúci bromo vodík, pri teplote 15 až 80 “C.h by bromination in an aqueous medium at room temperature in a yield of 23% [G. R. Barker, N. G. Luthy: J. Chem. Soc. 1956. 920] or in acetic acid in a yield of more than 90% (crude product) [J. Wojciechowski: Acta Polon. Pharm. 18, 409 (1961): PL 42, 976]. The disadvantage of the first process is the work in an aqueous medium in which the amino group in position 6 of the compound of the formula II is hydrolyzed in part. In the second process, the hydrobromic acid formed by the reaction also causes undesired reactions. The formation of impurities in the reaction results in a substantial reduction in the yields of purification of the compound of formula 1 and also in a reduction in the quality of the product after recrystallization, which results from a comparison of the melting point of the product according to the procedure described in the second liter. reference (265 ° C) and the procedure of the 1st lit. reference (278-280 ° C). This process is overcome by a process for the preparation of a compound of formula I according to the invention, which consists in brominating a compound of formula II in an acetic acid medium in the presence of sodium or potassium acetate, which bind hydrogen bromide liberating in the reaction at a temperature of 15 to 80 ° C.
Postup podťa vynálezu sa uskutečňuje tak,The process according to the invention is carried out in such a way that
CS 267 380 B1 2 že sa 1,0 mól. diel zlúčeniny vzorca II a 1,0 až 1,1 mól. diel octanu sodného alebo draselného suspenduje v kyselině octovej a za miešania sa přidává 1,0 až 1,1 mól. dielu brómu pri teplote miestnosti. Po doreagovaní, ktoré sa prejaví odfarbením reakčnej zmesi sa zlúčenina vzorca I odsaje, premyje vodou a prekryštalizujc z vody. Nakoniec sa vysuší za zvýšenej teploty, s výhodou vo vákuu.CS 267 380 B1 2 that 1.0 mol. part of the compound of formula II and 1.0 to 1.1 mol. part of the sodium or potassium acetate is suspended in acetic acid and 1.0 to 1.1 mol are added with stirring. part of bromine at room temperature. After the reaction, which is indicated by decolorization of the reaction mixture, the compound of the formula I is filtered off with suction, washed with water and recrystallized from water. Finally, it is dried at elevated temperature, preferably in vacuo.
Zlúčenina vzorca II sa móže najprv rozpustit’ varom s kyselinou octovou, potom sa přidá octan sodný alebo draselný a po ochladení na cca 60 až 70 °C sa zaháji pridávanie brómu po malých dávkách počas cca 15 min. Reakčná zmes sa po vychladení spracuje analogicky ako v predošlom postupe. Molárne poměry reaktantov sú taktiež analogické ako v predošlom postupe.The compound of formula II can first be dissolved by boiling with acetic acid, then sodium or potassium acetate is added and, after cooling to about 60-70 ° C, the addition of bromine is started in small portions over about 15 minutes. After cooling, the reaction mixture is worked up analogously to the preceding procedure. The molar ratios of the reactants are also analogous to the previous procedure.
Hlavnou výhodou postupu podťa vynálezu je získanie čistejšej zlúčeniny vzorca I vďaka likvidácii v reakcii sa uvoťňujúceho bromovodíka, čo vyplývá napr. z porovnania teplot topenia a v dosiahnutí vyšších výťažkov prekryštalizovaného produktu.The main advantage of the process according to the invention is that a purer compound of formula I is obtained by eliminating the hydrogen bromide liberated in the reaction, which results in e.g. from a comparison of melting points and in obtaining higher yields of recrystallized product.
V ďalšom je predmet vynálezu popísaný v príkladoch prevedenia bez toho, že by sa na ne obmedzoval.In the following, the subject matter of the invention is described in the exemplary embodiments without being limited thereto.
Příklad 1Example 1
K zmesi 14,1 g (0,10 mól) zlúčeniny vzorca II, 15,0 g (0,11 mól) octanu sodného krystalického a 100 ml kyseliny octovej sa za miešania přidává po malých dávkách počas cca 15 min. 17,58 g (0,11 mól) brómu. Hustá suspenzia sa na doreagovanie mieša pri teplote miestnosti ešte 1 h, produkt sa odsaje, premyje studenou vodou a prekryštalizuje z vody. Získá sa 18,0 g (81,8% teorie) zlúčeniny vzorca 1 s 1.1. 280 až 283 °C. Prvý lit. odkaz udává 1.1. 278 až 280 °C (H2O) a druhý lit. odkaz udává 265 °C (H2o). Pre C5H6BrN3O2 (220,0) vypočítané: 27,29 % C, 2,75 % H, 19,10 %N, 36,32 % Br; nájdené: 26,97 % C, 2,64 % H, 19,14 % N, 36,10 % Br.To a mixture of 14.1 g (0.10 mol) of the compound of formula II, 15.0 g (0.11 mol) of crystalline sodium acetate and 100 ml of acetic acid are added in small portions over about 15 minutes with stirring. 17.58 g (0.11 mol) of bromine. The thick suspension is stirred at room temperature for a further 1 h to react, the product is filtered off with suction, washed with cold water and recrystallized from water. 18.0 g (81.8% of theory) of the compound of the formula I with 1.1 are obtained. 280-283 ° C. The first lit. the reference indicates 1.1. 278-280 ° C (H 2 O) and second lit. reference indicates 265 ° C (H 2 O). For C 5 H 6 BrN 3 O 2 (220.0) calculated: 27.29% C, 2.75% H, 19.10% N, 36.32% Br; Found: 26.97% C, 2.64% H, 19.14% N, 36.10% Br.
Příklad 2Example 2
14,1 g (0,10 mól) zlúčeniny vzorca II sa rozpustí zahriatím do varu v 750 ml kyseliny octovej, přidá sa 10,8 g (0,11 mól) octanu draselného, vzniklý roztok sa ochladí na 70 °C a přidává sa k němu po malých dávkách I7,58g (0,11 mól) brómu počas cca 0,5 h. Reakčná zmes sa mieša do vychladnutia na teplotu miestnosti, produkt sa odsaje, premyje vodou a prekryštalizuje z vody. Získá sa 17,6 g (80,0 % teorie) zlúčeniny vzorca I s 1.1. 279 až 282 °C.14.1 g (0.10 mol) of the compound of formula II are dissolved by heating to boiling in 750 ml of acetic acid, 10.8 g (0.11 mol) of potassium acetate are added, the resulting solution is cooled to 70 ° C and to it after small doses of I7.58 g (0.11 mol) of bromine for about 0.5 h. The reaction mixture is stirred to cool to room temperature, the product is filtered off with suction, washed with water and recrystallized from water. 17.6 g (80.0% of theory) of the compound of the formula I with 1.1 are obtained. 279-282 ° C.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS883553A CS267380B1 (en) | 1988-05-25 | 1988-05-25 | Method of 6-amino-5-bromo-1-methyl-1 h-pyrimidine-2,4-dione preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS883553A CS267380B1 (en) | 1988-05-25 | 1988-05-25 | Method of 6-amino-5-bromo-1-methyl-1 h-pyrimidine-2,4-dione preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CS355388A1 CS355388A1 (en) | 1989-06-13 |
CS267380B1 true CS267380B1 (en) | 1990-02-12 |
Family
ID=5375946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS883553A CS267380B1 (en) | 1988-05-25 | 1988-05-25 | Method of 6-amino-5-bromo-1-methyl-1 h-pyrimidine-2,4-dione preparation |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS267380B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107936022A (en) * | 2017-11-30 | 2018-04-20 | 郑州大学 | Xanthine LSD1 inhibitor and its preparation method and application |
-
1988
- 1988-05-25 CS CS883553A patent/CS267380B1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107936022A (en) * | 2017-11-30 | 2018-04-20 | 郑州大学 | Xanthine LSD1 inhibitor and its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
CS355388A1 (en) | 1989-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6194439B1 (en) | Tricyclic polyhydroxylic tyrosine kinase inhibitors | |
JP2682705B2 (en) | A method for producing a 2,6-dichlorophenylaminobenzeneacetic acid derivative and a diphenylamine derivative. | |
US4556739A (en) | 3,4-Dialkoxy-2-alkylcarbonyl analino compounds | |
CS267380B1 (en) | Method of 6-amino-5-bromo-1-methyl-1 h-pyrimidine-2,4-dione preparation | |
JPS6176476A (en) | Xanthone derivative | |
KR910003709B1 (en) | Process for the preparation of butyl 3'-(1h-tetrazole-5-yl)oxanylrate | |
JPH07121944B2 (en) | Method for producing N-lower 1-methyl-10α-methoxyl millicergor | |
WO1984000957A1 (en) | 4-amino-tetrahydro-2-naphthoic acid derivatives | |
JPH01221365A (en) | Novel production of compound | |
JPS624247A (en) | Manufacture of 4,4'-dinitrodibenzyls | |
JPH02149550A (en) | N-(2-carboxy-3',4'-dimethoxy-cynnamoyl)-anthranilic acid, and production thereof | |
JP2000501705A (en) | Method for producing 3-amino-1,2,4-benzotriazine dioxide | |
JP2549931B2 (en) | Pyrimidobenzimidazole derivative | |
US3919312A (en) | Intermediates for preparing acridines | |
JPS6160832B2 (en) | ||
US4087437A (en) | 2-Phenyl-5-benzoxazolylalkanoic acid purification process | |
JP3347745B2 (en) | How to make ketoprofen | |
JPS627895B2 (en) | ||
KR810000888B1 (en) | Process for preparing indoles derivatives | |
JP3987130B2 (en) | Method for producing imidazole compound | |
JPH03503891A (en) | Production of 2,6-dioxopiperidine derivatives | |
JPS5916878A (en) | Production of 2,4-dihydroxy-3-acetylquinoline | |
JPS59148770A (en) | 2,4-dichloro-5-thiazole carboxaldehyde and manufacture | |
JPH0245467A (en) | Production of 1-(p-tertiary butylphenyl)-4-(4'- (alpha-hydroxy-diphenylmethyl)-1'-piperidinyl) butanol | |
JP2815647B2 (en) | Method for producing antiallergic agent intermediate |